Coronavirus vaccine - summary of Yellow Card reporting (up to 28 April)

The overall case incidence of thromboembolic events with concurrent thrombocytopenia reported in recipients of the Covid-19 Vaccine AstraZeneca was 10.5 per million doses. There is now some evidence the rate is higher in females, although this is not seen across all age groups.

Medicines and Healthcare products Regulatory Agency